BioSpace News Archive

Drug Development

Alterity Therapeutics Doses First Patient in ATH434 Phase 2 Clinical Trial in Multiple System Atrophy

Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), today announced the first patient has been dosed in the Company’s Phase 2 clinical trial of ATH434 in Multiple System Atrophy (MSA), a rare and highly debilitating Parkinsonian disorder.

July 6, 2022
·
4 min read
Pharmaceutical Grade Phycocyanin Market Size, Share, Growth, Trends, Report 2022-2030

The global Pharmaceutical Grade Phycocyanin market size is estimated to be worth US$ 26 million in 2021 and is forecast to a readjusted size of US$ 37 million by 2030 with a CAGR of 5.3% during the forecast period 2022-2030.

July 6, 2022
·
3 min read
Platinum based Cancer Drug Market Size, Share, Growth, Trends, Report 2022-2030

The global Platinum based Cancer Drug market size is estimated to be worth US$ 1541.9 million in 2021 and is forecast to a readjusted size of US$ 1862.2 million by 2030 with a CAGR of 2.7% during the forecast period 2022-2030.

July 6, 2022
·
3 min read
Sickle Cell Anemia Therapeutics Market Size, Share, Growth, Trends, Report 2022-2030

The global Sickle Cell Anemia Therapeutics market size is projected to reach US$ 9388.1 million by 2030, from US$ 3344 million in 2021, at a CAGR of 15.7% during 2022-2030.

July 6, 2022
·
4 min read
Somatostatin Market Size, Share, Growth, Trends, Report 2022-2030

The global Somatostatin market size is estimated to be worth US$ 336.6 million in 2021 and is forecast to a readjusted size of US$ 722.9 million by 2030 with a CAGR of 11.4% during the forecast period 2022-2030.

July 6, 2022
·
3 min read
Tyrosine Kinase JAK Inhibitors Market Size, Share, Growth, Trends, Report 2022-2030

The global Tyrosine Kinase JAK Inhibitors market size is estimated to be worth US$ 30480 million in 2021 and is forecast to a readjusted size of US$ 550830 million by 2030 with a CAGR of 50.6% during the forecast period 2022-2030.

July 6, 2022
·
3 min read
Transdermal Drug Patches Market Size, Share, Growth, Trends, Report 2022-2030

The global Transdermal Drug Patches market size is estimated to be worth US$ 6658 million in 2021 and is forecast to a readjusted size of US$ 8379.6 million by 2030 with a CAGR of 3.3% during the forecast period 2022-2030.

July 6, 2022
·
4 min read
Biotech Bay

Calyxo Raises $32.7 Million in Series C Financing to Support Novel Approach to Treating Kidney Stones

Calyxo, Inc., a medical device company focused on improving care for patients with kidney stones by delivering next generation treatment solutions, has announced the closing of a $32.7 million Series C financing round led by Questa Capital and CRG.

July 6, 2022
·
4 min read
Natural Killer (NK) Cell Therapeutics Market to See Remarkable CAGR Growth of 40.9% with Share, Size, Key Players, and Trends forecast

Natural Killer (NK) Cell Therapeutics marketing report provides complete background analysis of the industry which includes an assessment of the parental market.

July 6, 2022
·
6 min read
Researchers create a single-cell framework to potentially enhance CAR T-cell therapy

St. Jude Children’s Research Hospital scientists have demonstrated that the long-term performance of cancer-killing chimeric antigen receptor (CAR) T cells can, in some cases, be predicted before treatment.

July 6, 2022
·
6 min read